NUTEX InvestmentsBUD:NUTEX -0.37%50 Median PS Value is Ft5.65 as of Jul. 03, 2026, which is 100% below its 10-year median of 205.71. GuruFocus rates BUD:NUTEX with a GF Score™ of 50/100 and a GF Value™ of Ft13.80 (Fairly Valued). The stock has 3 warning signs investors should review. Among 545 Drug Manufacturers companies, NUTEX Investments ranks worse than 93.76% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for NUTEX Investments's Median PS Value or its related term are showing as below:
BUD:NUTEX'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 2.37 Med: 205.71 Max: 2395
Current: 2.37
During the past 13 years, the highest Price to Median PS Value of NUTEX Investments was 2395.00. The lowest was 2.37. And the median was 205.71.
BUD:NUTEX's Price-to-Median-PS-Value is ranked worse than 93.76% of 545
companies
in the Drug Manufacturers industry
Industry Median: 0.86
vs BUD:NUTEX: 2.37
NUTEX Investments (BUD:NUTEX) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
NUTEX Investments's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
13.40
/
5.65
=
2.37
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NUTEX Investments Median PS Value Related Terms
NUTEX Investments Median PS Value Historical Data
* Premium members only.
The historical data trend for NUTEX Investments's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BUD:NUTEX vs ZTS, UTHR, VTRS: Median PS Value Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, NUTEX Investments's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NUTEX Investments Price-to-Median-PS-Value vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, NUTEX Investments's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where NUTEX Investments's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 1883.3333.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. NUTEX Investments's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was Ft0.003.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NUTEX Investments (BUD:NUTEX) has a Median PS Value of Ft5.65 as of Jul. 03, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on NUTEX Investments and its competitors. This is 97% below median its historical median of 205.71. Over the past decade, NUTEX Investments' Median PS Value has ranged from 2.37 to 2,395.00. According to the industry distribution chart, NUTEX Investments ranks #511 out of 545 companies in the Drug Manufacturers industry, placing it in the top 93.8%.
Is NUTEX Investments' Median PS Value too high?
NUTEX Investments' current Median PS Value of Ft5.65 is 97% below median its 10-year median of 205.71. Over the past 10 years, this metric has ranged from a low of 2.37 to a high of 2,395.00. Based on the distribution chart, NUTEX Investments ranks #511 out of 545 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, NUTEX Investments has a GF Score™ of 50/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does NUTEX Investments' Median PS Value compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, NUTEX Investments ranks #511 out of 545 companies for Median PS Value. This places NUTEX Investments in the lower half of its industry. The industry median Median PS Value is 0.86. Historically, NUTEX Investments' own Median PS Value has ranged from 2.37 to 2,395.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Drug Manufacturers company?
The median Median PS Value among Drug Manufacturers companies is 0.86, based on 545 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on NUTEX Investments and its competitors. For the Drug Manufacturers industry, the median Median PS Value is 0.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NUTEX Investments's current Median PS Value is Ft5.65, which is 97% below median its own 10-year median of 205.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NUTEX Investments stock overvalued right now?
Based on GuruFocus' analysis, NUTEX Investments (BUD:NUTEX) is currently considered Fairly Valued. The stock's GF Value™ is Ft13.80, compared to a current price of Ft13.40 — trading 2.9% below its estimated fair value. The current Median PS Value is Ft5.65, which is 97% below median its 10-year median of 205.71. NUTEX Investments' overall GF Score™ is 50/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For NUTEX Investments (BUD:NUTEX), the current Median PS Value is Ft5.65 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is NUTEX Investments (BUD:NUTEX) Overvalued in 2026?
Based on GuruFocus' analysis, NUTEX Investments stock appears to be undervalued.
The current stock price of Ft13.40 is trading 2.9% below its estimated GF Value™ of Ft13.80.
GuruFocus considers NUTEX Investments to be Fairly Valued.
Key valuation signals for BUD:NUTEX:
Median PS Value: Ft5.65 (97% below median its 10-year median of 205.71)
GF Value™: Ft13.80 vs. price of Ft13.40 (2.9% below fair value)
No single metric tells the full story. See the BUD:NUTEX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
NUTEX Investments PLC operates as a drug manufacturer in Hungary. The company is engaged in production of products that focuses on health, vitality, and natural ingredients.
50GF Score
Get the complete analysis for BUD:NUTEX
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BUD:NUTEX has been successfully added to your 
